Flagship Pioneering Inc.

Q3 2021 13F Holdings Report, Stock Holdings

Notable people
Noubar B. Afeyan
Signature - Title
Noubar B. Afeyan, Ph.D. - Chief Executive Officer
Location
Cambridge, MA
Holdings as of
September 30, 2021
Value $
$0
Num holdings
13
Date filed
11/15/2021, 04:01 PM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q2 2021 - Aug 16, 2021
Next filing
Q4 2021 - Feb 14, 2022
Our algorithm has found invalid data in this filing
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2021 Q3 compared to 2021 Q2 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Noubar B. Afeyan, Ph.D. Chief Executive Officer Cambridge, Massachusetts 11/15/2021

Other Included Managers (7):

Num Name Location File Number
1 Flagship Ventures Fund V General Partner LLC Cambridge, MA 028-18466
2 Flagship Ventures Fund IV General Partner LLC Cambridge, MA 028-17238
3 Noubar B. Afeyan Cambridge, MA 028-19988
4 Flagship Opportunities Fund I General Partner LLC 028-20999
5 Flagship Pioneering Special Opportunities Fund II General Partner LLC 028-20997
6 Nutritional Health Fund LTP General Partner LLC 028-21001
7 Flagship Pioneering Fund VI General Partner LLC 028-20998